SynthesisJournal of infection and public health2021

Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials.

Tejas K Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.